May 2023

Bloomfield LE et al. SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022. Emerg Infect Dis. 2023;29(6):1162-1172. https://doi.org/10.3201/eid2906.230130
Full text

Brannock, M.D et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun 14, 2914 (2023). https://doi.org/10.1038/s41467-023-38388-7
Full text

DeCuir J et al. Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023. MMWR Morb Mortal Wkly Rep 2023;72:463–468. DOI: http://dx.doi.org/10.15585/mmwr.mm7217a3
Full text

Gui YZ et al. Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial. EBioMedicine. 2023 May;91:104586. doi: 10.1016/j.ebiom.2023.104586. Epub 2023 Apr 24. PMID: 37099843; PMCID: PMC10124970.
Full text

Gupta V et al. Severity and mortality associated with COVID-19 among children hospitalised in tertiary care centres in India: a cohort study. The Lancet Reg Health South East Asia. 2023 May 08. DOI:https://doi.org/10.1016/j.lansea.2023.100203
Full text

Hill JA et al. SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study, eClinicalMedicine (2023). DOI: 10.1016/j.eclinm.2023.101983
Full text

Hu Y et al. Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes. Vaccine. 2023 May 2;41(18):3003-3010. doi: 10.1016/j.vaccine.2023.03.056. Epub 2023 Mar 30. PMID: 37037708; PMCID: PMC10060199.
Full text

Huang T et al. Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study. Lancet Respir Med. 2023 May 17:S2213-2600(23)00129-7. doi: 10.1016/S2213-2600(23)00129-7. Epub ahead of print. PMID: 37209700.
Full text

Kharbanda EO et al. COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion. JAMA Netw Open. 2023;6(5):e2314350. doi:10.1001/jamanetworkopen.2023.14350
Full text 

Lam ICH et al. Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK. EClinicalMedicine. 2023 Jun;60:102000. doi: 10.1016/j.eclinm.2023.102000. Epub 2023 May 11. PMID: 37197226; PMCID: PMC10173760.
Full text

Li B et al. Efficacy and safety of acupuncture for post-COVID-19 depression: a protocol for systematic review and meta-analysis. BMJ Open. 2023 May 11;13(5):e071169. doi: 10.1136/bmjopen-2022-071169. PMID: 37169492; PMCID: PMC10186080.
Full text

Ljung R et al. Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study BMJ 2023; 381 :e074778 doi:10.1136/bmj-2023-074778
Full text

Link-Gelles R et al. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023. MMWR Morb Mortal Wkly Rep 2023;72:579–588. DOI: http://dx.doi.org/10.15585/mmwr.mm7221a3
Full text 

Liu S et al. The effectiveness of COVID-19 vaccination against all-cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the "Dynamic Zero Policy" in mainland China. Diabetes Res Clin Pract. 2023 May 8;200:110694. doi: 10.1016/j.diabres.2023.110694. Epub ahead of print. PMID: 37164159; PMCID: PMC10165863.
Full text

Lui DTW et al. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong. JAMA Netw Open. 2023;6(5):e2314393. doi:10.1001/jamanetworkopen.2023.14393
Full text

Meller S et al. Canine Olfactory Detection of SARS-CoV-2-Infected Humans – a Systematic Review. Annals of Epidemiology. 2023 May 19. https://doi.org/10.1016/j.annepidem.2023.05.002
Full text

Men K et al. Estimate the incubation period of coronavirus 2019 (COVID-19). Comput Biol Med. 2023 May;158:106794. doi: 10.1016/j.compbiomed.2023.106794. Epub 2023 Mar 30. PMID: 37044045; PMCID: PMC10062796.
Full text

Murphy C et al. Nonpharmaceutical interventions for managing SARS-CoV-2. Curr Opin Pulm Med. 2023 May 1;29(3):184-190. doi: 10.1097/MCP.0000000000000949. Epub 2023 Mar 1. PMID: 36856551; PMCID: PMC10090342.
Full text

Prather AA et al. Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study. Sci Rep 13, 6505 (2023). https://doi.org/10.1038/s41598-023-33320-x
Full text

Sorrell TC et al. Long COVID in Australia: achieving equitable access to supportive health care. Med J Aust. 2023 May 10. doi: 10.5694/mja2.51950. Epub ahead of print. PMID: 37164340.
Full text

Sperry MM et al. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients, PLOS Computational Biology (2023). DOI: 10.1371/journal.pcbi.1011050
Full text

Takeshi A et al. Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan, Open Forum Infectious Diseases, 2023;, ofad240, https://doi.org/10.1093/ofid/ofad240
Full text

Wang M et al. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Front Immunol. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336. PMID: 37205106; PMCID: PMC10185909.
Full text

Wang Z et al. The emerging antimicrobial resistance crisis during the COVID-19 surge in China. Lancet Microbe. 2023 May;4(5):e290-e291. doi: 10.1016/S2666-5247(23)00038-1. Epub 2023 Feb 10. PMID: 36780910; PMCID: PMC9917447.
Full text

Weiss A et al. Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19. JAMA. Published online May 22, 2023. doi:10.1001/jama.2023.8674
Full text

Yu MKL et al. Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases. Hum Vaccin Immunother. 2023 May 9:2206278. doi: 10.1080/21645515.2023.2206278. Epub ahead of print. PMID: 37157992.
Full text

Zhang H et al.. Advances in developing ACE2 derivatives against SARS-CoV-2. Lancet Microbe. 2023 May;4(5):e369-e378. doi: 10.1016/S2666-5247(23)00011-3. Epub 2023 Mar 16. PMID: 36934742; PMCID: PMC10019897.
Full text

Zhang H et al. Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity. Nature. 2023 May 2. doi: 10.1038/s41586-023-06127-z. Epub ahead of print. PMID: 37130545.
Full text

Zhang X et al. Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine. Inflamm Res. 2023 May;72(5):989-1000. doi: 10.1007/s00011-023-01723-1. Epub 2023 Apr 1. PMID: 37004547; PMCID: PMC10066982.
Full text

April 2023

Ambrose N et al. Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open. 2023;6(4):e239694. doi:10.1001/jamanetworkopen.2023.9694
Full text

Áñez G et al. Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(4):e239135. doi:10.1001/jamanetworkopen.2023.9135
Full text

Chang L et al. Changes in Brain Activation Pattern During Working Memory Tasks in People With Post-COVID Condition and Persistent Neuropsychiatric Symptoms. Neurology. 2023 Apr 10.1212/WNL.0000000000207309; DOI: 10.1212/WNL.0000000000207309
Full text

Chaichana U et al. Definition of Post–COVID-19 Condition Among Published Research Studies. JAMA Netw Open. 2023;6(4):e235856. doi:10.1001/jamanetworkopen.2023.5856
Full text

Cini C et al. Inter-hospital transfer and clinical outcomes for people with COVID-19 admitted to intensive care units in Australia: an observational cohort study. Med J Aust. 2023 Apr 10. doi: 10.5694/mja2.51917. Epub ahead of print. PMID: 37037671.
Full text

DeSilva MB et al. Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. J Infect Dis. 2023 Apr 18;227(8):961-969. doi: 10.1093/infdis/jiac458. PMID: 36415904.
Full text

Dorney I et al. Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data. JAMA Ophthalmol. 2023 Apr 13:e230610. doi: 10.1001/jamaophthalmol.2023.0610. Epub ahead of print. PMID: 37052897; PMCID: PMC10102921.
Full text

European Society of Microbiology and Infectious Diseases. Omicron appears more deadly than seasonal influenza, study suggests. EurekAlert News Reslease. 2023 Apr 6.
Full text

Fortin A et al. (2023). Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19. Clinical Microbiology and Infection. doi.org/10.1016/j.cmi.2023.03.019.
Full text

Firestein MR et al. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Netw Open. 2023;6(4):e237396. doi:10.1001/jamanetworkopen.2023.7396
Full text

Fung KW et al. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med. 2023 Apr 17;20(4):e1004194. doi: 10.1371/journal.pmed.1004194. Epub ahead of print. PMID: 37068113.
Full text

Gao L et al. Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial. Lancet Child Adolesc Health. 2023 Apr;7(4):269-279. doi: 10.1016/S2352-4642(22)00376-5. Epub 2023 Feb 17. PMID: 36803632; PMCID: PMC9937662.
Full text

Hesse E M et al. COVID-19 Vaccine Safety First Year Findings in Adolescents. Pediatrics. 2023 Apr 21. https://doi.org/10.1542/peds.2022-060295
Full text

Jackson C et al. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Resp Med. 2023 Apr 15. DOI:https://doi.org/10.1016/S2213-2600(23)00124-8
Full text

Kip K E et al. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19. Annals of Int Med. 2023 Apr. https://doi.org/10.7326/M22-1286
Full text

Li et al. mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia. Vaccine. 2023 Apr doi: https://doi.org/10.1016/j.vaccine.2023.01.075.
Full text

Lim Y et al. Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea. JAMA Netw Open. 2023;6(4):e239840. doi:10.1001/jamanetworkopen.2023.9840
Full text

Liu, W.J et al. Surveillance of SARS-CoV-2 at the Huanan Seafood Market. Nature (2023). https://doi.org/10.1038/s41586-023-06043-2
Full text

McMaster C et al. COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology (Oxford). 2023 Apr 3;62(4):1460-1466. doi: 10.1093/rheumatology/keac503. PMID: 36069664; PMCID: PMC9494403.
Full text

Mitchell R et al. Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022. JAMA Netw Open. 2023;6(4):e239050. doi:10.1001/jamanetworkopen.2023.9050
Full text

Mourad A et al. Dexamethasone for Inpatients With COVID-19 in a National Cohort. JAMA Netw Open. 2023;6(4):e238516. doi:10.1001/jamanetworkopen.2023.8516
Full text

Pittet L et al. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. NEJM. 2023 Apr 27. DOI: 10.1056/NEJMoa2212616
Full text

Reis G et al. Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19. A Randomized Platform Trial. Annals of Inter Med. 2023 Apr 18. https://doi.org/10.7326/M22-3305
Full text

RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. 2023 Apr 12. DOI:https://doi.org/10.1016/S0140-6736(23)00510-X
Full text

Selvakumar J et al. Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Netw Open. 2023;6(3):e235763. doi:10.1001/jamanetworkopen.2023.5763
Full text 

Seyed Arad Moghadasi et al. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Sci. Adv.9,eade8778(2023).DOI:10.1126/sciadv.ade8778
Full text

Sharma, C et al. High risk of autoimmune diseases after COVID-19. Nat Rev Rheumatol (2023). https://doi.org/10.1038/s41584-023-00964-y
Full text

Spungen H et al. Completeness and Spin of medRxiv Preprint and Associated Published Abstracts of COVID-19 Randomized Clinical Trials. JAMA. 2023;329(15):1310–1312. doi:10.1001/jama.2023.1784
Full text

Tsang NNY et al. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12. PMID: 36521506; PMCID: PMC9744442.
Full text

Xie R et al. Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong. Nat Commun. 2023 Apr 27;14(1):2422. doi: 10.1038/s41467-023-38201-5. PMID: 37105966; PMCID: PMC10134727.
Full text

Xie Y et al. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ 2023 Apr 25; 381 doi: https://doi.org/10.1136/bmj-2022-074572
Full text

Zakia H et al.  (2023) Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLoS ONE 18(4): e0284075. https://doi.org/10.1371/journal.pone.0284075
Full text

March 2023

Alvergne A et al. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience. 2023 Mar 15. DOI:https://doi.org/10.1016/j.isci.2023.106401
Full text

Barateaux V et al. Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination. 2023 Mar 15. Science Tranlational Medicine. 2023 Mar 15. https://doi.org/10.1126/scitranslmed.ade0550
Full text

Bramante C et al. Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial. Lancet Pre-print.  Available at SSRN: https://ssrn.com/abstract=4375620 or http://dx.doi.org/10.2139/ssrn.4375620
Full text

Byambasuren O et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385
Full text

Bennet C M. Covid-19 in Australia: How did a country that fought so hard for extra time end up so ill prepared? BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p469
Full text

Calvert C. et al. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries. Nat Hum Behav (2023). https://doi.org/10.1038/s41562-023-01522-y
Abstract

Cheung M W et al. Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients. medRxiv 2023.03.01.23286513; doi: https://doi.org/10.1101/2023.03.01.23286513
Full text

Deo R et al. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Annals of Int Med. 2023 Mar. https://doi.org/10.7326/M22-2381
Full text

DeVries A et al. One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database. JAMA Health Forum. 2023;4(3):e230010. doi:10.1001/jamahealthforum.2023.0010
Full text

Edlow AG et al. Sex-Specific Neurodevelopmental Outcomes Among Offspring of Mothers With SARS-CoV-2 Infection During Pregnancy. JAMA Netw Open. 2023;6(3):e234415. doi:10.1001/jamanetworkopen.2023.4415
Full text

Fai E Y et al. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Int Med. 2023 March 14. Doi: https://doi.org/10.7326/M22-3057
Full text

Fang MC et al. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023;6(3):e232338. doi:10.1001/jamanetworkopen.2023.2338
Full text

Gao F et al Robust T cell responses to Pfizer/BioNTech vaccine compared to infection and evidence of attenuated peripheral CD8+ T cell responses due to COVID-19. Immunity. 2023 Mar 15. DOI:https://doi.org/10.1016/j.immuni.2023.03.005
Full text

Gilbert G L. Aged care residents — and everybody else — would benefit from better control of COVID‐19 transmission. Med J Aust 2023; 218 (4): 166-167. || doi: 10.5694/mja2.51843
Full text

Goligher EC et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. Published online March 21, 2023. doi:10.1001/jama.2023.3651
Full text

Harris E. Nasally Administered Monoclonal Antibody for COVID-19. JAMA. Published online March 22, 2023. doi:10.1001/jama.2023.4000
Full text

Heine J et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinical Med. 2023 February 27. DOI:https://doi.org/10.1016/j.eclinm.2023.101874
Full text

Jang EJ et al. Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection. JAMA Netw Open. 2023;6(3):e232578. doi:10.1001/jamanetworkopen.2023.2578
Full text

Koirala A et al. Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet. 2023 March 22. DOI:https://doi.org/10.1016/j.lanwpc.2023.100736
Full text

Labbé V et al. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Intern Med. Published online March 22, 2023. doi:10.1001/jamainternmed.2023.0456
Full text

Maia I S et al. Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial.  The Lancet. 2023 March 07. DOI:https://doi.org/10.1016/j.lana.2023.100466
Full text

McGarry B E et al. Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes. NEJM. 2023 March 23. DOI: 10.1056/NEJMoa2210063
Full text

O’Brien WJ et al.  Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods. JAMA Netw Open. 2023;6(3):e234876. doi:10.1001/jamanetworkopen.2023.4876
Full text

Ockene MW et al. Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure, The Journal of Clinical Endocrinology & Metabolism, 2023;, dgad130, https://doi.org/10.1210/clinem/dgad130
Full text

Schweizer S et al. COVID-19 Risks Across the Lifespan (CORAL) Consortium. Association of Antenatal COVID-19–Related Stress With Postpartum Maternal Mental Health and Negative Affectivity in Infants. JAMA Netw Open. 2023;6(3):e232969. doi:10.1001/jamanetworkopen.2023.2969
Full text

Spiegel K et al. A meta-analysis of the associations between insufficient sleep duration and antibody response to vaccination. Current Biology. 2023 Mar 13. DOI:https://doi.org/10.1016/j.cub.2023.02.017
Full text

Sumner MW et al. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328. doi:10.1001/jamanetworkopen.2023.2328
Full text

Sun Y et al. Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts BMJ 2023; 380 :e074224 doi:10.1136/bmj-2022-074224
Full text

Tanne J H. Covid-19: US studies show racial and ethnic disparities in long covid BMJ 2023 March 06. doi: https://doi.org/10.1136/bmj.p535
Full text

The Lancet. Long COVID: 3 years in. The Lancet. 2023 March 23. DOI:https://doi.org/10.1016/S0140-6736(23)00493-2
Full text

Tsampasian V et al. Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0750
Full text

Wang Y et al. Sarcopenia and COVID-19 Outcomes. Clin Interv Aging. 2023 Mar 9;18:359-373. doi: 10.2147/CIA.S398386. PMID: 36923269; PMCID: PMC10010141.
Full text

Wang H et al. Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data. The Lancet. 2023 Feb 27. DOI:https://doi.org/10.1016/j.lanwpc.2023.100716
Full text

Xie Y et al. Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records BMJ 2023; 380 :e072705 doi:10.1136/bmj-2022-072705
Full text

Xie Y et al. Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0743
Full text

Xu, E et al. Long-term gastrointestinal outcomes of COVID-19. Nat Commun 14, 983 (2023). https://doi.org/10.1038/s41467-023-36223-7
Full text

Zhang XJ et al. Prevalence of Myopia in Children Before, During, and After COVID-19 Restrictions in Hong Kong. JAMA Netw Open. 2023;6(3):e234080. doi:10.1001/jamanetworkopen.2023.4080
Full text

(Updated 7 June 2023)